Outlook Therapeutics Announces Pricing of $55.0 Million Public Offering of Common Stock and Warrants
Published by outlooktherapeutics.com. Opens in a new tab.
More news
- Ocean Capital Acquisition Corporation Prices $100 Million Initial Public Offering
- Aeon Acquisition I Corp. Announces Pricing of $125 Million Initial Public Offering
- Perimeter Medical Imaging AI Closes Life Offering
- ZeroToOne.AI Acquires GroundTruth to Deploy at Scale an AI Driven Predictive Intelligence Platform for Enterprise Decision Systems